ASYMPTOMATIC BECKER MUSCULAR DYSTROPHY IN A FAMILY WITH A MULTIEXON DELETION

被引:49
作者
Ferreiro, Veronica [1 ]
Giliberto, Florencia [2 ]
Noelia Muniz, Garcia M. [2 ]
Francipane, Liliana [1 ]
Marzese, Diego M. [3 ]
Mampel, Alejandra [4 ]
Roque, Maria [3 ]
Frechtel, Gustavo D. [1 ]
Szijan, Irene [2 ]
机构
[1] Univ Buenos Aires, Clin Hosp Jose de San Martin, Div Genet, RA-1120 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Pharm & Biochem, Dept Genet & Mol Biol, RA-1120 Buenos Aires, DF, Argentina
[3] Natl Univ Cuyo, Fac Med Sci, Dept Cellular & Mol Biol, Mendoza, Argentina
[4] Natl Univ Cuyo, Fac Med Sci, Inst Med Genet, Mendoza, Argentina
关键词
asymptomatic DMD/BMD; multiple-exon skipping; DMD molecular diagnosis; DMD gene therapy; antisense; DMD; DUCHENNE;
D O I
10.1002/mus.21193
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report a Becker muscular dystrophy (BMD) family with one 5-year-old affected patient and a 69-year-old asymptomatic grandfather. Dystrophin gene multiplex polymerase chain reaction and multiplex ligation-dependant probe amplification analysis showed that both males carried an in-frame deletion of exons 45-55. Segregation analysis revealed two additional asymptomatic boys in this family. Our finding supports previous predictions that exons 45-55 are the optimal multiexon skipping target in antisense gene therapy to transform the severe Duchenne muscular dystrophy into the milder BMD, or even asymptomatic, phenotype.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 13 条
[1]   Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63 % of patients with Duchenne muscular dystrophy [J].
Beroud, Christophe ;
Tuffery-Giraud, Sylvie ;
Matsuo, Masafumi ;
Hamroun, Dalil ;
Humbertclaude, Wronique ;
Monnier, Nicole ;
Moizard, Marie-Pierre ;
Voelckel, Marie-Antoinette ;
Calemard, Laurence Michel ;
Boisseau, Pierre ;
Blayau, Martine ;
Philippe, Christophe ;
Cossee, Mireille ;
Pages, Michel ;
Rivier, Franois ;
Danos, Olivier ;
Garcia, Luis ;
Claustres, Mireille .
HUMAN MUTATION, 2007, 28 (02) :196-202
[2]   Function and genetics of dystrophin and dystrophin-related proteins in muscle [J].
Blake, DJ ;
Weir, A ;
Newey, SE ;
Davies, KE .
PHYSIOLOGICAL REVIEWS, 2002, 82 (02) :291-329
[3]  
Dabby R, 2006, ISRAEL MED ASSOC J, V8, P110
[4]  
Ferreiro Veronica, 2005, Mol Diagn, V9, P67, DOI 10.2165/00066982-200509020-00003
[5]  
Ferreiro Veronica, 2004, Mol Diagn, V8, P115, DOI 10.2165/00066982-200408020-00006
[6]   Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Backer muscular dystrophy [J].
Kerst, B ;
Mennerich, D ;
Schuelke, M ;
Stoltenburg-Didinger, G ;
von Moers, A ;
Gossrau, R ;
van Landeghem, FKH ;
Speer, A ;
Braun, T ;
Hübner, C .
NEUROMUSCULAR DISORDERS, 2000, 10 (08) :572-577
[7]  
KOENIG M, 1989, AM J HUM GENET, V45, P498
[8]   Splicing intervention for Duchenne muscular dystrophy [J].
McClorey, G ;
Fletcher, S ;
Wilton, S .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (05) :529-534
[9]   An Explanation for the Phenotypic Differences between Patients Bearing Partial Deletions of the DMD Locus [J].
Monaco, Anthony P. ;
Bertelson, Corlee J. ;
Liechti-Gallati, Sabina ;
Moser, Hans ;
Kunkel, Louis M. .
GENOMICS, 1988, 2 (01) :90-95
[10]   RAPID ISOLATION OF HIGH MOLECULAR-WEIGHT PLANT DNA [J].
MURRAY, MG ;
THOMPSON, WF .
NUCLEIC ACIDS RESEARCH, 1980, 8 (19) :4321-4325